Clinical Trial Update: The Effect of Metformin on Obesity and Metabolic Disturbance in Patients Taking Clozapine [Phase 4]

View source ↗

Summary

Phase 4 trial investigating the effect of metformin on obesity and metabolic disturbance in patients taking clozapine for schizophrenia; study terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• Clozapine (Clozapine)
• metformin (metformin)

Snippet

Sponsor: Seoul National University Hospital | Conditions: Schizophrenia | Phase 4 | Status: TERMINATED